Skip to content

Annexon ANNX Investment Purchases

Investment Purchases at other companies

Dianthus Therapeutics logo
Dianthus TherapeuticsDNTH
$238.59M+254%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$20.14M-84.0%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$452.25M+1,714%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$0-100%
Amylyx Pharmaceuticals, Inc. logo
Amylyx Pharmaceuticals, Inc.AMLX
$19.74M-81.0%
Jade Biosciences, Inc. Common Stock logo
Jade Biosciences, Inc. Common StockJBIO
$73.9M

Other financials

Income statement

See full
Operating income-$46.1M+19.8%
Net income-$44.1M+18.8%
EPS (diluted)-$0.23+37.8%

Balance sheet

See full
Cash & equivalents$175.2M+80.4%
Total debt$25.4M-10.2%
Total equity$204.5M-16.1%
Total assets$262.9M-13.2%

Cash flow

See full
Operating cash flow-$46.8M+6.5%
CapEx--100%
Free cash flow-$46.8M+6.6%

Valuation

See full
Market cap$868.37M+233%
Enterprise value$718.59M+274%

Returns & leverage

See full
Return on equity-87.6%+42.3pp
Debt / equity0.1×0.0×
Current ratio6.4×-1.6×

Where this comes from

Reported directly by Annexon in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt.

The official record: Annexon’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Annexon's investment purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Annexon's investment purchases?
Annexon (ANNX) reported investment purchases of $5.94M in Q1 2026.
How has Annexon's investment purchases changed year-over-year?
Annexon's investment purchases decreased by 90.4% year-over-year, from $61.81M to $5.94M.
What is the long-term trend for Annexon's investment purchases?
Over 4 years (2021 to 2025), Annexon's investment purchases has grown at a -1.5% compound annual growth rate (CAGR), from $225.6M to $212.21M.
What does investment purchases mean?
Cash spent purchasing investment securities across all categories.